Tag:
Jennerex
Latest Headlines
Latest Headlines
Engineered smallpox vaccine helps liver cancer patients
San Francisco-based Jennerex reported that liver cancer patients who received the high dose of the company's genetically engineered smallpox vaccine lived a median of 13.8 months versus just 6.7
Virus sent on seek-and-destroy mission against cancer
Drug-delivery technology is all about selectively killing disease while leaving healthy cells alone. Turns out, you can engineer a virus to do the same thing, according to a report in Technology
Jennerex cheered by early efficacy data for cancer-killing virus
A small, mid-stage study of Jennerex's genetically engineered virus offered some important preliminary proof-of-concept data on its ability to zero in on cancer cells with just a single infusion.
Transgene teams with Jennerex in $116M cancer pact
France's Transgene is hitching its wagon and a $116 million slate of milestones to a new collaboration with San Francisco-based Jennerex on a virus-based cancer cell-killing therapy. In the pact the
Companies explore promise of oncolytic immunity
FierceVaccines recently caught up with 2009 Fierce 15 Winner BioVex , which was born in the lab of University College London scientist Robert Coffin and later moved to Massachusetts. Dr. Coffin
